ATE442364T1 - Kristalline form von linezolid - Google Patents

Kristalline form von linezolid

Info

Publication number
ATE442364T1
ATE442364T1 AT03769887T AT03769887T ATE442364T1 AT E442364 T1 ATE442364 T1 AT E442364T1 AT 03769887 T AT03769887 T AT 03769887T AT 03769887 T AT03769887 T AT 03769887T AT E442364 T1 ATE442364 T1 AT E442364T1
Authority
AT
Austria
Prior art keywords
crystalline form
linezolide
linezolid
preparation
relates
Prior art date
Application number
AT03769887T
Other languages
English (en)
Inventor
Rao Dodda Mohan
Reddy Pingili Krishna
Original Assignee
Symed Labs Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34430675&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE442364(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Symed Labs Ltd filed Critical Symed Labs Ltd
Application granted granted Critical
Publication of ATE442364T1 publication Critical patent/ATE442364T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT03769887T 2003-10-16 2003-10-16 Kristalline form von linezolid ATE442364T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IN2003/000336 WO2005035530A1 (en) 2003-10-16 2003-10-16 A novel crystalline form of linezolid

Publications (1)

Publication Number Publication Date
ATE442364T1 true ATE442364T1 (de) 2009-09-15

Family

ID=34430675

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03769887T ATE442364T1 (de) 2003-10-16 2003-10-16 Kristalline form von linezolid

Country Status (10)

Country Link
US (4) US7714128B2 (de)
EP (3) EP2100884A1 (de)
AT (1) ATE442364T1 (de)
AU (1) AU2003278592A1 (de)
DE (2) DE60329237D1 (de)
DK (1) DK1673370T3 (de)
ES (3) ES2331001T3 (de)
HU (1) HUE051230T2 (de)
PT (1) PT1673370E (de)
WO (1) WO2005035530A1 (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1673370E (pt) 2003-10-16 2009-11-05 Symed Labs Ltd Forma cristalina de linezolida
WO2005099353A2 (en) 2004-04-19 2005-10-27 Symed Labs Limited A novel process for the preparation of linezolid and related compounds
CA2572207A1 (en) * 2004-06-29 2006-10-19 Teva Pharmaceutical Industries Ltd. Solid forms of linezolid and processes for preparation thereof
EP2174935A1 (de) * 2004-06-29 2010-04-14 Teva Pharmaceutical Industries Ltd Linezolidzusammensetzungen
EP1866295A2 (de) 2005-02-24 2007-12-19 Teva Pharmaceutical Industries Ltd Verfahren zur herstellung von linezolidzwischenprodukten
DK1749517T3 (da) * 2005-07-20 2008-11-03 Teva Pharma Stabil farmaceutiske sammensætning af linezolid form IV
EP2033960A3 (de) 2007-09-04 2009-04-29 Dipharma Francis S.r.l. Kristalline Linezolidhydratform und Linezolidsalze
IT1390957B1 (it) * 2008-07-07 2011-10-27 Dipharma Francis Srl Sali di linezolid e loro uso nella preparazione di forme cristalline di linezolid
US20090093631A1 (en) * 2007-09-06 2009-04-09 Ben-Zion Dolitzky Processes for the preparation of a linezolid intermediate, linezolid hydroxide
WO2009140466A2 (en) * 2008-05-14 2009-11-19 Dr. Reddy's Laboratories Ltd. Linezolid co-crystals
EP2493867A1 (de) 2009-10-28 2012-09-05 Synthon BV Verfahren zur herstellung einer kristallinen form von linezolid
WO2011050826A1 (en) * 2009-10-28 2011-05-05 Synthon B.V. Process for making crystalline form a of linezolid
US20130137864A1 (en) 2009-12-26 2013-05-30 Jayaraman Venkat Raman Process for the preparation of linezolid
EP2603505A1 (de) 2010-08-11 2013-06-19 Synthon BV Verfahren zur herstellung von linezolid
EP2690100A1 (de) 2010-08-11 2014-01-29 Synhton B.V. Verfahren zur Linezpolid Herstellung
WO2012029074A2 (en) 2010-09-02 2012-03-08 Hetero Research Foundation Pharmaceutical compositions of linezolid
CN102070548B (zh) * 2011-01-13 2012-12-26 浙江新东港药业股份有限公司 一种晶型ⅰ型利奈唑胺的蒸发结晶工艺
US20140114065A1 (en) 2011-02-24 2014-04-24 Lee Phama Limited Anhydrous linezolid crystalline form-ii
EP2683696A1 (de) 2011-03-09 2014-01-15 Synthon BV Verfahren zur herstellung einer kristallinen form von linezolid
CN105461648B (zh) * 2011-05-03 2018-01-12 江苏豪森药业集团有限公司 利奈唑胺的晶型及其制备方法
ITMI20111311A1 (it) * 2011-07-14 2013-01-15 Dipharma Francis Srl Sali di linezolid e loro uso nella preparazione di forme cristalline di linezolid
WO2013072923A1 (en) 2011-09-19 2013-05-23 Cadila Healthcare Limited Process for the preparation of crystalline linezolid
WO2013093751A1 (en) * 2011-12-24 2013-06-27 Alembic Pharmaceuticals Limited Packaging for linezolid
WO2013111048A1 (en) 2012-01-24 2013-08-01 Jubilant Life Sciences Limited Improved process for the preparation of stable crystalline form-i of linezolid, substantially free of residual solvent
WO2013120496A1 (en) 2012-02-14 2013-08-22 Pharmathen S.A. Process for the preparation of linezolid in crystalline form and salts thereof
WO2013190559A1 (en) * 2012-06-19 2013-12-27 Symed Labs Limited Improved processes for the preparation of linezolid crystalline form iii
US9492459B2 (en) 2012-08-10 2016-11-15 Indoco Remedies Limited Pharmaceutical composition of linezolid
WO2014071990A1 (en) 2012-11-09 2014-05-15 Synthon Bv Process for making linezolid
WO2014118809A1 (en) 2013-01-29 2014-08-07 Actavis Group Ptc Ehf. Pharmaceutical composition with linezolid
WO2015068121A1 (en) 2013-11-06 2015-05-14 Unimark Remedies Ltd. Process for preparation of crystalline form i of linezolid and its compositions
CN105254580B (zh) * 2014-04-22 2018-01-02 江苏豪森药业集团有限公司 利奈唑胺晶型的制备方法
WO2016113751A1 (en) * 2015-01-13 2016-07-21 Nosch Labs Private Limited Process for preparing crystalline linezolid form-iii
WO2018051360A1 (en) * 2016-09-16 2018-03-22 Lee Pharma Limited A novel process for the preparation of crystalline linezolid form-iii
JP7101694B2 (ja) 2016-11-16 2022-07-15 ペルシカ ファーマシューティカルズ リミテッド 腰痛のための抗生物質製剤
EP3709970B1 (de) 2017-11-16 2025-05-14 Persica Pharmaceuticals Ltd. Linezolidformulierungen
CN110194750A (zh) * 2019-06-19 2019-09-03 四川美大康华康药业有限公司 一种利奈唑胺的制备方法及精制方法
EP4415722A1 (de) 2021-10-12 2024-08-21 Persica Pharmaceuticals Ltd. Behandlung von rückenschmerzen

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US583870A (en) * 1897-06-01 Wrench
DE2810349A1 (de) 1978-03-10 1979-09-20 Kali Chemie Pharma Gmbh Verfahren zur herstellung von 3-hydroxy-6-phenyl-1,2,3,4-tetrahydro- 1,5-benzodiazocinen
FR2506769A2 (fr) 1978-06-09 1982-12-03 Delalande Sa Para-((cyano-5 n pentyl-1) phenyl)-3 methoxymethyl-5 oxazolidinone-2, son procede de preparation et ses applications en therapeutique
US4340606A (en) 1980-10-23 1982-07-20 E. I. Du Pont De Nemours And Company 3-(p-Alkylsulfonylphenyl)oxazolidinone derivatives as antibacterial agents
FR2608604B1 (fr) 1986-12-19 1989-04-28 Delalande Sa Derives 5-hydroxyethyles de l'oxazolidinone-2, leurs procedes de preparation et leurs applications en therapeutique
US5006528A (en) 1988-10-31 1991-04-09 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives
DE9310451U1 (de) 1993-03-05 1994-06-30 Landis & Gyr Business Support Ag, Zug Steuer- bzw. Regeleinrichtung für Gas-Feuerungsautomaten von Heizungsanlagen
DE59306401D1 (de) 1993-03-11 1997-06-12 Landis & Gyr Tech Innovat Brennerregler
US5688792A (en) * 1994-08-16 1997-11-18 Pharmacia & Upjohn Company Substituted oxazine and thiazine oxazolidinone antimicrobials
MY115155A (en) 1993-09-09 2003-04-30 Upjohn Co Substituted oxazine and thiazine oxazolidinone antimicrobials.
ES2166073T3 (es) * 1996-04-11 2002-04-01 Upjohn Co Procedimiento para preparar oxazolidinonas.
EP0890791A1 (de) 1997-07-11 1999-01-13 Electrowatt Technology Innovation AG Steuer- und Regelgerät für einen Brenner
DK1028940T3 (da) 1997-11-07 2007-07-30 Pharmacia & Upjohn Co Llc Fremgangsmåde til fremstilling af oxazolidinoner
US6444813B2 (en) 2000-02-02 2002-09-03 Pharmacia & Upjohn Company Linezolid-crystal form II
AR027261A1 (es) * 2000-02-02 2003-03-19 Upjohn Co Linezolid forma cristalina ii
MY127336A (en) 2000-03-22 2006-11-30 Upjohn Co Container for linezolid iv solution
DE10037585A1 (de) * 2000-08-02 2002-02-14 Valeo Schalter & Sensoren Gmbh Rückstellvorrichtung für einen Blinkerschalter in Kraftfahrzeugen
KR100818875B1 (ko) 2000-08-14 2008-04-01 테바 파마슈티컬 인더스트리즈 리미티드 리스페리돈의 제조
WO2002072066A1 (en) * 2001-02-05 2002-09-19 Pharmacia & Upjohn Company Composition for rectal delivery of an oxazolidinone antibacterial drug
JP2005504007A (ja) * 2001-04-20 2005-02-10 ファルマシア アンド アップジョン カンパニー リミティド ライアビリティー カンパニー オキサゾリジノンの製法
CN1155585C (zh) 2001-12-19 2004-06-30 中国医学科学院医药生物技术研究所 3,5－取代噁唑烷酮衍生物及其制备方法和应用
US6992219B2 (en) 2002-08-09 2006-01-31 Cephalon France Modafinil polymorphic forms
PT1673370E (pt) 2003-10-16 2009-11-05 Symed Labs Ltd Forma cristalina de linezolida
WO2005099353A2 (en) 2004-04-19 2005-10-27 Symed Labs Limited A novel process for the preparation of linezolid and related compounds
EP2174935A1 (de) 2004-06-29 2010-04-14 Teva Pharmaceutical Industries Ltd Linezolidzusammensetzungen
EP1768967B1 (de) 2004-07-20 2009-04-22 Symed Labs Limited Neue zwischenprodukte für linezolid und verwandte verbindungen

Also Published As

Publication number Publication date
EP2902386A1 (de) 2015-08-05
HUE051230T2 (hu) 2021-03-01
US20060128703A1 (en) 2006-06-15
US20080091011A1 (en) 2008-04-17
US7718799B2 (en) 2010-05-18
EP2100884A1 (de) 2009-09-16
DE09163348T1 (de) 2010-01-07
DE60329237D1 (de) 2009-10-22
WO2005035530A1 (en) 2005-04-21
US7718800B2 (en) 2010-05-18
US7714128B2 (en) 2010-05-11
AU2003278592A1 (en) 2005-04-27
ES2331001T3 (es) 2009-12-18
US20080090824A1 (en) 2008-04-17
DK1673370T3 (da) 2009-12-07
US7732597B2 (en) 2010-06-08
EP1673370B1 (de) 2009-09-09
ES2803516T3 (es) 2021-01-27
PT1673370E (pt) 2009-11-05
ES2331454T1 (es) 2010-01-05
US20080090820A1 (en) 2008-04-17
EP1673370A1 (de) 2006-06-28
EP2902386B1 (de) 2020-04-08

Similar Documents

Publication Publication Date Title
ATE442364T1 (de) Kristalline form von linezolid
DE60315368D1 (de) Korrektur des Weissabgleichs
CY2013036I2 (el) Συνθεσεις εμβολιου κατα της ναϊσσερια, που περιεχουν εναν συνδυασμο αντιγονων
DE60333020D1 (de) Anzeigeeinrichtung des dünnen typs
EP1633307A4 (de) Modulation der survivin-expression
BR0308452A (pt) composições farmacêuticas e métodos de preparação de composição farmacêutica
NO20071642L (no) N-Benzensulfonylsubstituerte anilino-pyrimidinanaloger
ECSP095220A (es) Derivados de n-fenil-2-pirimidin-amina
IS7716A (is) Hringlaga heterósambönd
DK1613304T3 (da) DPP-IV-inhibitorer
IL159418A0 (en) Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
ATE428701T1 (de) Kristalline form von bisä(e)-7-ä4-(4-fluorphenyl)-6-isopropyl-2-
DE60111497D1 (de) Linezolid-krystall form ii
DK1380121T3 (da) Fremgangsmåde til fremstilling af oxazolidinoner
BR0307071A (pt) ésteres hidroxamato do ácido n-(fenil 4-substituìdo)-antranìlico
ATE491814T1 (de) Herstellung von titanoxid
DE60201084D1 (de) Herstellung von cyclischen esteroligomeren
IL166483A0 (en) Pharmaceutical compositions containing ciclesonideand an antihistamine
DE50213650D1 (de) Einrichtung zur Herstellung von Stapelpaketen
ATE444290T1 (de) Oxazolderivate von tetracyclinen
DE60107074D1 (de) Kristallin form ii von cabergolin
DK1644385T3 (da) Siliciumforbindelser og deres anvendelse
ATE474824T1 (de) Herstellung von olefinen
DE602004030779D1 (de) Angehen des problems des schrittmachersyndroms
DE602004013599D1 (de) Herstellung von somatostatinpeptiden

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1673370

Country of ref document: EP